Introduction: Liposomes remain at the forefront of drug and vaccine design owing to their
well-documented abilities to act as delivery vehicles. Nevertheless, the concept of liposomes …

Liposomes not only offer the ability to enhance drug delivery, but can effectively act as
vaccine delivery systems and adjuvants. Their flexibility in size, charge, bilayer rigidity and …

Liposomes are widely utilized as a carrier to improve therapeutic efficacy of agents thanks to
their merits of high loading capacity, targeting delivery, reliable protection of agents, good …

The discovery of liposomes in 1965 by Bangham and coworkers changed the prospects of
drug delivery systems. Since then, the application of liposomes as vaccine delivery systems …

A range of particulate delivery systems have been considered as vaccine adjuvants. Of
these systems, liposomes offer a range of advantages including versatility and flexibility in …

Liposomes (phospholipid bilayer vesicles) are versatile and robust delivery systems for
induction of antibody and T lymphocyte responses to associated subunit antigens. In the last …

Cationic liposomes are lipid-bilayer vesicles with a positive surface charge that have re-
emerged as a promising new adjuvant technology. Although there is some evidence that …

The application of cationic liposomes as vaccine delivery systems and adjuvants has been
investigated extensively over the last few decades. However, cationic liposomes are, in …

Vaccination remains a key tool in the protection and eradication of diseases. However, the
development of new safe and effective vaccines is not easy. Various live organism based …

Introduction: Liposomes are well-known as drug carriers, and are now critical components of
two of six types of adjuvants present in licensed vaccines. The liposomal vaccine adjuvant …